John C Aplin - Net Worth and Insider Trading
John C Aplin Net Worth
The estimated net worth of John C Aplin is at least $505,301 dollars as of 2024-04-18. John C Aplin is the Director of Endocyte Inc and owns about 21,063 shares of Endocyte Inc (ECYT) stock worth over $505,301. Details can be seen in John C Aplin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John C Aplin has not made any transactions after 2011-12-16 and currently still holds the listed stock(s).
Transaction Summary of John C Aplin
John C Aplin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John C Aplin owns 2 companies in total, including Endocyte Inc (ECYT) , and Stereotaxis Inc (STXS) .
Click here to see the complete history of John C Aplin’s form 4 insider trades.
Insider Ownership Summary of John C Aplin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ECYT | Endocyte Inc | 2018-12-21 | director |
| STXS | Stereotaxis Inc | 2004-08-11 | director |
John C Aplin Latest Holdings Summary
John C Aplin currently owns a total of 1 stock. John C Aplin owns 21,063 shares of Endocyte Inc (ECYT) as of December 16, 2011, with a value of $505,301.
Latest Holdings of John C Aplin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ECYT | Endocyte Inc | 2011-12-16 | 21,063 | 23.99 | 505,301 |
Holding Weightings of John C Aplin
John C Aplin Form 4 Trading Tracker
According to the SEC Form 4 filings, John C Aplin has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the acquisition of 20,000 shares on December 16, 2011, which cost John C Aplin around $65,400.
Insider Trading History of John C Aplin
- 1
John C Aplin Trading Performance
GuruFocus tracks the stock performance after each of John C Aplin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John C Aplin is 70.26%. GuruFocus also compares John C Aplin's trading performance to market benchmark return within the same time period. The performance of stocks bought by John C Aplin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John C Aplin's insider trading performs compared to the benchmark.
Performance of John C Aplin
Average Relative Return
217.97%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 17.32 | 70.26 | 138.89 | 217.97 | 77.9 | 24.3 |
| Relative Return to S&P 500(%) | 11.63 | 55.13 | 128.79 | 202.07 | 56.9 | 6.93 |
John C Aplin Ownership Network
Ownership Network List of John C Aplin
Ownership Network Relation of John C Aplin
John C Aplin Owned Company Details
What does Endocyte Inc do?
Who are the key executives at Endocyte Inc?
John C Aplin is the director of Endocyte Inc. Other key executives at Endocyte Inc include VP Finance & Chief Acctg Off Beth Taylor , General Counsel David R. Mcavoy , and Chief Medical Officer Alison A. Armour .
Endocyte Inc (ECYT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Endocyte Inc (ECYT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endocyte Inc (ECYT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Endocyte Inc (ECYT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Endocyte Inc Insider Transactions
John C Aplin Mailing Address
Above is the net worth, insider trading, and ownership report for John C Aplin. You might contact John C Aplin via mailing address: One American Square Ste 2850, Indianapolis In 46282.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
